---
layout: single
title:  "The Molecular Biomarker Revolution in Metastatic NSCLC"
categories: oncology

---
Session from American Society for Clinical Pathology (ASCP) 2022 annual meeting discussing the latest on emerging Biomarkers, Immuno-oncology resistance mechanisms and treatment options (e.g. therapies involving CTLA-4 inhibitors) in metastatic NSCLC (Non-Small Cell Lung Cancer).

 
[Inside the Lab](https://podcasts.apple.com/us/podcast/inside-the-lab/id1527274970?i=1000584959609)